Second, DPP-4 inhibitors (DPP-4I) suppress systemic inflammation [6], and diminish tissue damage in a mouse model of lipopolysaccharide (LPS)-induced Acute Respiratory Distress Syndrome (ARDS) [7]. This evidence concerns the gene DPP4 and acute respiratory distress syndrome.